. Oxygen homeostasis is critical for cell survival, normal development, and tissue function. Low levels of oxygen (hypoxia) activate the transcription factors known as hypoxia-inducible factors (HIFs). HIFs are the key regulators of the adaptive response to hypoxia, regulating genes involved in metabolic reprograming, angiogenesis, pluripotency and differentiation, epithelial-to-mesenchymal transition (EMT), and apoptosis. Accordingly, HIF activity is critical during many pathological processes, including cancer progression, obesity, heart disease, and stroke. The work proposed here focuses on HIF1A with the immediate goal of significantly advancing our mechanistic knowledge of the cellular response to hypoxia, and the ultimate goal of illuminating novel therapeutic strategies for human pathologies driven by HIF1A. A detailed dissection of the molecular mechanisms by which HIF1A and its cofactors regulate gene expression, both directly and indirectly, as well as the identification of the key genes required for the cellular adaptation to hypoxia will be critical to fully understand how different cell types and tissues react to this stress, and to envision how these responses can be manipulated during the course of disease. Using a combination of genomic, molecular biology, and functional approaches, this research proposal aims to: Define mechanisms driving cell type-specific gene expression upon activation of HIF1A by hypoxia. Elucidate the mechanisms of action of HIF1A transcriptional coactivators. Identify and characterize genes required for cell survival in hypoxia.
. Regulation of oxygen concentration is critical for cell survival, normal development, and tissue function. The Hypoxia Inducible Factors (HIFs) are key regulators of genes required for the adaptive response to low oxygen (hypoxia), and are involved in the etiology and progression of major medical conditions, including cancer, obesity, diabetes, heart disease, and stroke. The goal of this proposal is to significantly advance our mechanistic knowledge of the cellular response to hypoxia, with the ultimate goal of illuminating novel therapeutic strategies for human pathologies driven by HIFs.
| Abraham, Christopher G; Ludwig, Michael P; Andrysik, Zdenek et al. (2018) ?Np63? Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas. Cell Rep 24:3224-3236 |
| Galati, Domenico F; Sullivan, Kelly D; Pham, Andrew T et al. (2018) Trisomy 21 Represses Cilia Formation and Function. Dev Cell 46:641-650.e6 |
| Espinosa, Joaquín M (2017) On the Origin of lncRNAs: Missing Link Found. Trends Genet 33:660-662 |
| Liang, Kaiwei; Volk, Andrew G; Haug, Jeffrey S et al. (2017) Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia. Cell 168:59-72.e13 |
| Audetat, K Audrey; Galbraith, Matthew D; Odell, Aaron T et al. (2017) A Kinase-Independent Role for Cyclin-Dependent Kinase 19 in p53 Response. Mol Cell Biol 37: |
| Galbraith, Matthew D; Andrysik, Zdenek; Pandey, Ahwan et al. (2017) CDK8 Kinase Activity Promotes Glycolysis. Cell Rep 21:1495-1506 |
